United Bankshares Insider Adds Phantom Stock; Minimal Market Impact
Rhea-AI Filing Summary
United Bankshares, Inc. (UBSI) – Form 4 filed 08/06/2025
Director Clinton P. Winter reported a Code P acquisition of 278 phantom stock units at an average reference price of $35.7692. Phantom stock is settled in cash after the director leaves the company and therefore does not immediately dilute equity, but aligns compensation with share-price performance.
Following the transaction, Winter’s holdings stand at:
- Common stock – direct: 457,070 shares
- Common stock – indirect: 36,800 shares via Bray & Oakley Insurance and 1,000 shares held by spouse
- Phantom stock: 53,198 units (including the 278 newly acquired)
The purchase value is roughly $10k, a modest amount relative to the director’s existing stake and UBSI’s $5 bn+ market cap. No sales were reported. The filing signals continued insider alignment but is unlikely to be financially material for investors.
Positive
- Insider buy signal: Director chose to increase economic exposure, which can be interpreted as incremental confidence in UBSI’s prospects.
Negative
- Immaterial size: The 278-unit purchase (~$10k) is too small relative to existing holdings and market cap to be a strong bullish indicator.
Insights
TL;DR: Minor insider purchase; positive sentiment, immaterial size.
The Code P buy of 278 phantom units (<≈$10k) marginally increases Winter’s economic exposure to UBSI without adding share count. Combined direct and indirect common holdings already exceed 495k shares, so the incremental change is less than 0.1%. Such routine director compensation supports long-term alignment but does not alter the investment thesis or valuation. Insider activity screens will record it as a buy, offering a mildly positive signal yet not enough volume to sway institutional flows.
TL;DR: Standard deferred-comp plan action; neutral governance impact.
Phantom stock grants are typical board compensation tools that defer taxation and mirror shareholder returns. The Form 4 shows proper disclosure and no red flags: no Rule 10b5-1 plan, no option repricing, no related-party transactions. Because units settle in cash, shareholder dilution risk is nil. Governance takeaway is neutral; transparency maintained, insider alignment incrementally reinforced.
FAQ
How many UBSI phantom stock units did Director Clinton P. Winter acquire?
What is the price reference for the newly acquired UBSI phantom stock?
What are Clinton P. Winter’s total UBSI common stock holdings after the transaction?
Does the phantom stock purchase dilute existing UBSI shareholders?
Is this Form 4 filing considered materially significant to UBSI investors?